Tech Company Financing Transactions

QuVa Pharma Funding Round

QuVa Pharma closed a $41 million funding round on 7/26/2018. Backers included Oxford Finance and Silicon Valley Bank.

Transaction Overview

Company Name
Announced On
7/26/2018
Transaction Type
Debt
Amount
$41,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Sugar Creek Center Blvd. 250
Sugar Land, TX 77478
USA
Email Address
Overview
QuVa Pharma will be the industry's leading 503B platform and the partner of choice for compliance-oriented healthcare facilities looking to ensure quality, safe and consistent supply of medications.
Profile
QuVa Pharma LinkedIn Company Profile
Social Media
QuVa Pharma Company Twitter Account
Company News
QuVa Pharma News
Facebook
QuVa Pharma on Facebook
YouTube
QuVa Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stuart Hinchen
  Stuart Hinchen LinkedIn Profile  Stuart Hinchen Twitter Account  Stuart Hinchen News  Stuart Hinchen on Facebook
Chief Financial Officer
Brett Coverdale
  Brett Coverdale LinkedIn Profile  Brett Coverdale Twitter Account  Brett Coverdale News  Brett Coverdale on Facebook
Chief Operating Officer
Scott Aladeen
  Scott Aladeen LinkedIn Profile  Scott Aladeen Twitter Account  Scott Aladeen News  Scott Aladeen on Facebook
Vice President
Varsha Gaitonde
  Varsha Gaitonde LinkedIn Profile  Varsha Gaitonde Twitter Account  Varsha Gaitonde News  Varsha Gaitonde on Facebook
Vice President
Donna Kohut
  Donna Kohut LinkedIn Profile  Donna Kohut Twitter Account  Donna Kohut News  Donna Kohut on Facebook
Vice President
Travis Leeah
  Travis Leeah LinkedIn Profile  Travis Leeah Twitter Account  Travis Leeah News  Travis Leeah on Facebook
VP - Bus. Development
Peter Jenkins
  Peter Jenkins LinkedIn Profile  Peter Jenkins Twitter Account  Peter Jenkins News  Peter Jenkins on Facebook
VP - Human Resources
Tracey Gibbs
  Tracey Gibbs LinkedIn Profile  Tracey Gibbs Twitter Account  Tracey Gibbs News  Tracey Gibbs on Facebook
VP - Marketing
Michael Scouvart
  Michael Scouvart LinkedIn Profile  Michael Scouvart Twitter Account  Michael Scouvart News  Michael Scouvart on Facebook
VP - Operations
Michael Rutkowski
  Michael Rutkowski LinkedIn Profile  Michael Rutkowski Twitter Account  Michael Rutkowski News  Michael Rutkowski on Facebook
VP - Regulatory Affairs
David Short
  David Short LinkedIn Profile  David Short Twitter Account  David Short News  David Short on Facebook
VP - Sales
Ray Dixon
  Ray Dixon LinkedIn Profile  Ray Dixon Twitter Account  Ray Dixon News  Ray Dixon on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/26/2018: Patientco venture capital transaction
Next: 7/26/2018: Tally venture capital transaction

 

Share this article

 


News on VC Transactions

We report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary